Literature DB >> 2404100

AIDS as immune system activation. II. The panergic imnesia hypothesis.

M S Ascher1, H W Sheppard.   

Abstract

A hypothesis is presented in which HIV infection leads to immunodeficiency through indirect subversion of critical T cell regulatory mechanisms. Acting at the T cell receptor complex (TCR), viral components (gp120) mimic the natural ligands of CD4, molecules of the major histocompatibility complex (MHC), and deliver physiologically active, inappropriate signals resulting in generalized, uncontrolled lymphocyte activation, or "panergy." Clinical manifestations of panergy include autoimmune phenomena, lymphadenopathy, hyperglobulinemia, and symptoms mediated by lymphokines. Immunologic unresponsiveness occurs early in HIV infection prior to T cell depletion because activated cells do not respond to further stimulation. Ultimately, activation disrupts T cell homeostasis by interference with the generation of memory cells ("imnesia") and leads to net T cell loss, clonal deletion, and the development of AIDS. The clinical and immunologic features of HIV disease and AIDS are reviewed from this perspective. This hypothesis is consistent with the paucity of infected T cells, the clinical findings of both AIDS-related complex (ARC) and frank AIDS, the prolonged "incubation period," and a role for antigen-specific cofactors. Based on this view of HIV pathophysiology, therapeutic modalities should avoid immune stimulation and seek to block aberrant gp120 signals at CD4 and eliminate HIV-infected cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2404100

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  14 in total

1.  Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses.

Authors:  Z Grossman; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 2.  Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection.

Authors:  J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

Review 3.  Immune activation in the context of HIV infection.

Authors:  Z Bentwich; A Kalinkovich; Z Weisman; Z Grossman
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

4.  Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispecies.

Authors:  M A Ostrowski; D C Krakauer; Y Li; S J Justement; G Learn; L A Ehler; S K Stanley; M Nowak; A S Fauci
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Correlation of the percentage of activated, CD3 + DR + lymphocytes to serum neopterin level in HIV-seropositive haemophiliacs.

Authors:  K Pálóczi; E Ujhelyi; D Fuchs; R Mihalik; D Bánhegyi; S Berkessy; V Salavecz; H Wachter; S R Hollán; G Füst
Journal:  Klin Wochenschr       Date:  1991-02-26

Review 6.  Lentivirus-induced immune dysregulation.

Authors:  Mary B Tompkins; Wayne A Tompkins
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

7.  Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?

Authors:  Eduardo Samo Gudo; Nilesh B Bhatt; Dulce Ramalho Bila; Celina Monteiro Abreu; Amílcar Tanuri; Wilson Savino; Suse Dayse Silva-Barbosa; Ilesh V Jani
Journal:  BMC Infect Dis       Date:  2009-12-22       Impact factor: 3.090

8.  Comparison of activation marker and TCR V beta gene product expression by CD4+ and CD8+ T cells in peripheral blood and lymph nodes from HIV-infected patients.

Authors:  S Ramzaoui; F Jouen-Beades; F Michot; F Borsa-Lebas; G Humbert; F Tron
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

9.  HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo.

Authors:  Angélique Biancotto; Sarah J Iglehart; Christophe Vanpouille; Cristian E Condack; Andrea Lisco; Elke Ruecker; Ivan Hirsch; Leonid B Margolis; Jean-Charles Grivel
Journal:  Blood       Date:  2007-10-01       Impact factor: 22.113

10.  An octapeptide analogue of HIV gp120 modulates protein tyrosine kinase activity in activated peripheral blood T lymphocytes.

Authors:  D J Phipps; P Reed-Doob; D K MacFadden; J P Piovesan; G B Mills; D R Branch
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.